Drugs / KD7040
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00576108 | Nov 2007 → Jul 2008 | herpes zoster, neuropathy, painful, postherpetic neuralgia | Kalypsys, Inc. | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KD7040 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00576108 ↗ |
| Action | Inhibit | “Nitric oxide synthase, inducible inhibitor” CHEMBL1911882 ↗ |
| Modality | Small molecule | — CHEMBL1911882 ↗ |
| Route | Topical | “topical KD7040” NCT00576108 ↗ |
| Target | NOS2 | “Nitric oxide synthase, inducible inhibitor” CHEMBL1911882 ↗ |